Some States Limit Monoclonal Antibody Treatment to High-Risk, Unvaccinated Patients

September 23, 2021

(Medscape) – At least two states are recommending that doctors prioritize the limited supply of monoclonal antibody treatments for high-risk COVID-19 patients, including unvaccinated people who face severe disease, according to NBC News. Tennessee has said that nearly all vaccinated patients should receive lower priority to preserve supplies for those who remain most vulnerable. Alabama has also said that treatments should go to those who are most likely to be hospitalized. (Read Full Article)